Novavax (Estrasorb Assets) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Buyout/​LBO
  • Financing Rounds
  • 1

Novavax (Estrasorb Assets) General Information

Description

Provider of menopause-treatment line in North America. The Estrasorb (estradiol topical emulsion) is used to treat severe vasomotor symptoms associated with menopause and is available by prescription only.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Buildings and Property
Other Industries
Other Pharmaceuticals and Biotechnology
Pharmaceuticals
Biotechnology
Primary Office
  • 9920 Belward Campus Drive
  • Rockville, MD 20850
  • United States
+1 (240) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Novavax (Estrasorb Assets) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Novavax (Estrasorb Assets)‘s full profile, request access.

Request a free trial